Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Control Release ; 56(1-3): 75-83, 1998 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-9801431

RESUMO

The aim of this study was to investigate the potential application of thermoreversible gels formed by a xyloglucan polysaccharide derived from tamarind seed for rectal drug delivery. Xyloglucan that had been partially degraded by beta-galactosidase to eliminate 44% of galactose residues formed gels at concentrations of between 1 to 2% w/w at gelation temperatures decreasing over the range 27 to 22 degreesC with increasing concentration. The in vitro release of indomethacin and diltiazem from the enzyme-degraded xyloglucan gels followed root-time kinetics over a period of 5 h at 37 degreesC; the diffusion coefficients increasing with temperature increase between 10 and 37 degreesC. The in vitro release of indomethacin from the gels was significantly more sustained than from commercial suppositories. Measurement of plasma levels of indomethacin after rectal administration to rabbits of the gels and commercial suppositories containing an identical drug concentration indicated a broader absorption peak following administration of the gels, and a longer residence time. There was no significant difference in bioavailability of indomethacin when administered by these two vehicles. Morphological studies of rectal mucosa following a single administration of the gels showed no evidence of tissue damage. The results of this study suggest the potential of the enzyme-degraded xyloglucan gels as vehicles for rectal delivery of drugs.


Assuntos
Glucanos , Polissacarídeos/administração & dosagem , Polissacarídeos/química , Xilanos , Administração Retal , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/farmacocinética , Sequência de Carboidratos , Fármacos Cardiovasculares/administração & dosagem , Fármacos Cardiovasculares/farmacocinética , Química Farmacêutica , Preparações de Ação Retardada , Diltiazem/administração & dosagem , Diltiazem/farmacocinética , Portadores de Fármacos , Géis/administração & dosagem , Géis/química , Géis/farmacocinética , Temperatura Alta , Indometacina/administração & dosagem , Indometacina/farmacocinética , Masculino , Dados de Sequência Molecular , Polissacarídeos/farmacocinética , Coelhos , Supositórios
2.
Biol Pharm Bull ; 20(3): 288-91, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9084890

RESUMO

The effect of pulsed output ultrasound (1 MHz) with on/off ratios of 1:2, 1:4 and 1:9 on transdermal absorption of indomethacin from an ointment was studied in rats. Ultrasound energy was supplied for between 10 and 19 min at a range of intensities (1.0-2.5 W.cm-2), energy levels commonly used for therapeutic purposes. The on/off pulsed ratio, intensity and the time of application were found to play an important role in the transdermal phonophoretic delivery system of indomethacin; 1:2 pulsed output ultrasound appeared to be the most effective in improving the transdermal absorption. The highest penetration was observed at an intensity of 1.0 W.cm-2 and application time of 15 min. With pulsed output it was possible to use higher intensities of ultrasound without increasing skin temperature or damaging skin.


Assuntos
Anti-Inflamatórios não Esteroides/farmacocinética , Indometacina/farmacocinética , Absorção Cutânea/efeitos da radiação , Ultrassom , Administração Cutânea , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Área Sob a Curva , Indometacina/administração & dosagem , Masculino , Pomadas , Fonoforese , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...